The incidence and cost of severe sepsis in intensive care units;A súlyos szepszis gyakorisága és kezelé sének költsége intenzív osztályon

Orvosi Hetilap

Volumn 146, Issue 29, 2005, Pages 1543-1547

  Csomós, Ákos ^a   Hoffer, Gábor ^a   Fülesdi, Béla ^b   Ludwig, Endre ^a  

^a Kozponti Aneszteziologiai es Intenziv Betegellato Osztaly ^*  (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cost analysis; Intensive care; Sepsis

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; HOSPITAL COST; HOSPITALIZATION; HUMAN; HUNGARY; INCIDENCE; INTENSIVE CARE UNIT; MORTALITY; SEPSIS; COST; ECONOMICS; EUROPE; LENGTH OF STAY; STATISTICS;

COSTS AND COST ANALYSIS; EUROPE; HUMANS; HUNGARY; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 25444464160     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Angus, D. C., Linde-Zwirble, W. T., Clermont, G. és mtsai: Cost-effectiveness of drotrecogin alfa (activated) (Xigris) in severe sepsis. Crit. Care Med., 2002, 28, A1 (Supplement).
2. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J. és mtsai: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome and associated costs of care. Crit. Care Med., 2001, 29, 1303-1310.
3. Bone, R. C., Balk, R. A., Cerra, F. B. és mtsai: Definitions for sepsis
4. and organ failuire and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101, 1664-1655.
5. Brun-Buisson, C., Doyon, F., Carlet, J. és mtsai: Incidence, risk factors and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. JAMA, 1995, 274, 968-974.
6. Centers for Disease Control: Increase in national hospital discharge survey rates for septicaemia-United States, 1979-1987. JAMA., 1990, 263, 937-938.
7. Chalfin, D. B., Fein, A. M.: The economic impact and cost-effectiveness of monoclonal antibody therapy for sepsis. Clin. Infect. Dis., 1993, 17, 520-524.
8. Csomós, A., Janecskó, M.: Comparative costing analysis of 13 intensive care units in Hungary. Int. Care Med., 2002, 28, S66.
9. Edbrooke, D. L., Hibbert, C. L., Kingsley, J. M. és mtsai: The patient-related costs of care for sepsis patients in a United Kingdom adult general intensive care unit. Crit. Care Med., 1999, 27, 1760-1767.
10. Edbrooke, D. L., Hibbert, C. L., Ridley, S. és mtsai: The development of a method for comparative costing of individual intensive care units. Anaesthesia, 1999, 54, 110-120.
11. Kaló, Z., Járay, J., Nagy, J.: Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary. Progress in Transplantation, 2001, 11, 188-193.
12. Moerer, O., Schmid, A., Hofmann, M. és mtsai: Direct cost of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Int. Care Med., 2002, 28, 1440-1446.
13. Sasse, K. C., Nauenberg, E., Long, A. és mtsai: Long-term survival after intensive care unit admission with sepsis. Crit. Care Med., 1995, 23, 1040-1047.